Key facts
- CMR Surgical’s last known valuation is $2.7B (Jun 2021).
- It has raised $1.4B; the latest was Debt - General ($11.8M) in Dec 2025.
- Notable investors include SoftBank Investment Advisers, SoftBank Group, Lightrock, Chimera Capital, Ally Bridge Group — 26 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 26 names
- ·Watchlist + deal alerts for CMR Surgical
- ·The full record, as it builds
Funding rounds
No funding rounds for CMR Surgical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CMR Surgical
Developer of surgical robotic systems designed to bring the benefits of minimal access surgery to all patients. The company's systems are making minimal access surgery universally accessible and affordable by expanding the range of procedures that can be performed by robots, enabling surgeons to access three-dimensional, high-definition imagery along with feedback during the operation.
- Sector
- Healthcare
- HQ
- Cambridge, United Kingdom
- Founded
- 2014
- Employees
- 642
- Website
- cmrsurgical.com/
- Ownership
- Privately Held (backing)
CMR Surgical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CMR Surgical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CMR Surgical in its N-PORT filings yet. We sweep new filings monthly.